These are research findings only not medical claims and not a recommendation for human use
UAE expert warns of risks With drugs increasingly offered by non-healthcare providers and subscription-style programmes, clinicians say rush to scale is outpacing the clinical safeguards needed PUBLISHED: Tue 10 Feb 2026, 10:18 AM UPDATED: Tue 10 Feb 2026, 12:46 PM Weight-loss injections that were once tightly controlled medical treatments are now being marketed well beyond specialist clinics
A mild resurfacing complex lifts away buildup while replenishing hydration in a single step, leaving skin noticeably smoother and softer
Employers may also subsidize some or all of the manufacturer's monthly prescription costs, Barner said
As of April 2026, four oral GLP-1 medications are FDA-approved in the United States Rybelsus, Ozempic tablets, the Wegovy tablet, and Foundayo (orforglipron)
1% to 2%: We tend to use 1% to 2% niacinamide in formulas to help calm the skin and support the barrier, says Dr